NYSE:CBA

ClearBridge American Energy MLP Fund (CBA) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$6.75
$6.75
50-Day Range
N/A
52-Week Range
$6.53
$9.58
Volume
N/A
Average Volume
236,990 shs
Market Capitalization
$395.48 million
P/E Ratio
N/A
Dividend Yield
11.85%
Price Target
N/A

About ClearBridge American Energy MLP Fund

ClearBridge American Energy MLP Fund Inc. is a closed-ended equity mutual fund of funds launched and managed by Legg Mason Partners Fund Advisor, LLC. The fund is co-managed by ClearBridge Investments, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the energy sector. It primarily invests in equity securities of MLPs that are poised to benefit from the growing production and usage of natural gas, securities of entities holding primarily general partner or managing member interests in MLPs, and securities that are derivatives of interests in MLPs such as exchange traded funds. ClearBridge American Energy MLP Fund Inc. was formed on February 21, 2013 and is domiciled in the United States.

CBA Stock News Headlines

ClearBridge Large Cap Growth C
Pentagon contract could send this $2 AI stock soaring
Whenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...
ClearBridge Appreciation R LMPPX
ClearBridge Appreciation I SAPYX
Pentagon contract could send this $2 AI stock soaring
Whenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...
XEMOX - ClearBridge Energy MLP Opportunity Fund Inc.
ClearBridge Large Cap Value Fund;I
ClearBridge Dividend Strategy Fund;A
ClearBridge Dividend Strategy 1
ClearBridge Appreciation IS LMESX
ClearBridge Appreciation A SHAPX
ClearBridge Value A LGVAX
ClearBridge Select A LCLAX
CBA_old Historical Data
ClearBridge American Energy MLP Fund Inc. (CBA)
See More Headlines
Receive CBA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ClearBridge American Energy MLP Fund and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Finance
Industry
Management Investment, Open - Ended
Sub-Industry
N/A
Web
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$395.48 million
Optionable
Not Optionable
Beta
1.89
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Kenneth Donald Fuller (Age 60)
    Chairman, Chief Exec. Officer and Pres
  • Mr. Richard F. Sennett (Age 48)
    Principal Financial Officer and Principal Accounting Officer
  • Mr. Robert I. Frenkel (Age 64)
    Chief Legal Officer and Sec.
  • Mr. Theodore Paul Becker (Age 67)
    Chief Compliance Officer
  • Mr. Steven Frank (Age 51)
    Treasurer

CBA Stock Analysis - Frequently Asked Questions

Is ClearBridge American Energy MLP Fund a good dividend stock?

ClearBridge American Energy MLP Fund (NYSE:CBA) pays an annual dividend of $0.80 per share and currently has a dividend yield of 11.85%. CBA has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for CBA.

What other stocks do shareholders of ClearBridge American Energy MLP Fund own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ClearBridge American Energy MLP Fund investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Ares Capital (ARCC), Energy Transfer (ET), Fate Therapeutics (FATE), Amicus Therapeutics (FOLD), Madrigal Pharmaceuticals (MDGL), NuCana (NCNA), Rigel Pharmaceuticals (RIGL).

This page (NYSE:CBA) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners